Literature DB >> 15361072

Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract.

Catherine Robbe1, Calliope Capon, Bernadette Coddeville, Jean-Claude Michalski.   

Abstract

Purified human mucins from different parts of the intestinal tract (ileum, cecum, transverse and sigmoid colon and rectum) were isolated from two individuals with blood group ALe(b) (A-Lewis(b)). After alkaline borohydride treatment the released oligosaccharides were structurally characterized by nano-ESI Q-TOF MS/MS (electrospray ionization quadrupole time-of-flight tandem MS) without prior fractionation or derivatization. More than 100 different oligosaccharides, with up to ten monosaccharide residues, were identified using this technique. Oligosaccharides based on core 3 structures, GlcNAc(beta1-3)GalNAc (where GlcNAc is N-acetyl-D-glucosamine and GalNAc is N-acetylgalactosamine), were widely distributed in human intestinal mucins. Core 5 structures, GalNAc(alpha1-3)GalNAc, were also recovered in all fractions. Moreover, a comparison of the oligosaccharide repertoire, with respect to size, diversity and expression of glycans and terminal epitopes, showed a high level of mucin-specific glycosylation: highly fucosylated glycans, found specifically in the small intestine, were mainly based on core 4 structures, GlcNAc-(beta1-3)[GlcNAc(beta1-6)]GalNAc, whereas the sulpho-Le(X) determinant carrying core 2 glycans, Gal(beta1-3)[GlcNAc(beta1-6)]-GalNAc (where Gal is galactose), was recovered mainly in the distal colon. Blood group H and A antigenic determinants were present exclusively in the ileum and cecum, whereas blood group Sd(a)/Cad related epitopes, GalNAc(beta1-4)[NeuAc(alpha2-3)]Gal (where NeuAc is N-acetylneuraminate), were found to increase along the length of the colon. Our findings suggest that mucins create an enormous repertoire of potential binding sites for micro-organisms that could explain the regio-specific colonization of bacteria in the human intestinal tract.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361072      PMCID: PMC1134114          DOI: 10.1042/BJ20040605

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

2.  Bacterial glycosulphatases and sulphomucin degradation.

Authors:  A M Robertson; D P Wright
Journal:  Can J Gastroenterol       Date:  1997 May-Jun       Impact factor: 3.522

Review 3.  Mucin glycoproteins in colonic neoplasia.

Authors:  Y S Kim
Journal:  Keio J Med       Date:  1998-03

4.  Molecular cloning, gene organization and expression of the human UDP-GalNAc:Neu5Acalpha2-3Galbeta-R beta1,4-N-acetylgalactosaminyltransferase responsible for the biosynthesis of the blood group Sda/Cad antigen: evidence for an unusual extended cytoplasmic domain.

Authors:  Maria-Dolores Montiel; Marie-Ange Krzewinski-Recchi; Philippe Delannoy; Anne Harduin-Lepers
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

Review 5.  Pathways of O-glycan biosynthesis in cancer cells.

Authors:  I Brockhausen
Journal:  Biochim Biophys Acta       Date:  1999-12-06

6.  Sd(a)-antigen-like structures carried on core 3 are prominent features of glycans from the mucin of normal human descending colon.

Authors:  C Capon; E Maes; J C Michalski; H Leffler; Y S Kim
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

7.  Sulfated lewis X determinants as a major structural motif in glycans from LS174T-HM7 human colon carcinoma mucin.

Authors:  C Capon; J M Wieruszeski; J Lemoine; J C Byrd; H Leffler; Y S Kim
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

8.  Negative-ion electrospray mass spectrometry of neutral underivatized oligosaccharides.

Authors:  W Chai; V Piskarev; A M Lawson
Journal:  Anal Chem       Date:  2001-02-01       Impact factor: 6.986

9.  Disulfated oligosaccharides derived from tracheobronchial mucous glycoproteins of a patient suffering from cystic fibrosis.

Authors:  D L Chance; T P Mawhinney
Journal:  Carbohydr Res       Date:  1996-12-13       Impact factor: 2.104

10.  Oligosaccharide structures of human colonic mucin.

Authors:  D K Podolsky
Journal:  J Biol Chem       Date:  1985-07-15       Impact factor: 5.157

View more
  123 in total

Review 1.  Intestinal candyfloss.

Authors:  Inka Brockhausen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

Review 2.  Host Sialic Acids: A Delicacy for the Pathogen with Discerning Taste.

Authors:  Brandy L Haines-Menges; W Brian Whitaker; J B Lubin; E Fidelma Boyd
Journal:  Microbiol Spectr       Date:  2015-08

3.  Identifying human milk glycans that inhibit norovirus binding using surface plasmon resonance.

Authors:  Jing Shang; Vladimir E Piskarev; Ming Xia; Pengwei Huang; Xi Jiang; Leonid M Likhosherstov; Olga S Novikova; David S Newburg; Daniel M Ratner
Journal:  Glycobiology       Date:  2013-09-10       Impact factor: 4.313

4.  Generation of 13C-Labeled MUC5AC Mucin Oligosaccharides for Stable Isotope Probing of Host-Associated Microbial Communities.

Authors:  Clayton Evert; Tina Loesekann; Ganapati Bhat; Asif Shajahan; Roberto Sonon; Parastoo Azadi; Ryan C Hunter
Journal:  ACS Infect Dis       Date:  2019-01-24       Impact factor: 5.084

5.  Mixed effects of caffeic acid phenethyl ester (CAPE) on joint inflammation, bone loss and gastrointestinal inflammation in a murine model of collagen antibody-induced arthritis.

Authors:  Bonnie Williams; Eleni Tsangari; Romany Stansborough; Victor Marino; Melissa Cantley; Anak Dharmapatni; Rachel Gibson; Egon Perilli; Tania Crotti
Journal:  Inflammopharmacology       Date:  2017-01-03       Impact factor: 4.473

6.  Glycosylation of human fetal mucins: a similar repertoire of O-glycans along the intestinal tract.

Authors:  Catherine Robbe-Masselot; Emmanuel Maes; Monique Rousset; Jean-Claude Michalski; Calliope Capon
Journal:  Glycoconj J       Date:  2008-09-20       Impact factor: 2.916

7.  Roles and regulation of the mucus barrier in the gut.

Authors:  Steve Cornick; Adelaide Tawiah; Kris Chadee
Journal:  Tissue Barriers       Date:  2015-04-03

8.  A novel incompatibility group X3 plasmid carrying bla NDM-1 encodes a small RNA that regulates host fucose metabolism and biofilm formation.

Authors:  Chuan Huang; Liang-Zhe Liu; Hoi-Kuan Kong; Carmen O K Law; Pham Quynh Hoa; Pak-Leung Ho; Terrence C K Lau
Journal:  RNA Biol       Date:  2020-06-28       Impact factor: 4.652

9.  L-fucose utilization provides Campylobacter jejuni with a competitive advantage.

Authors:  Martin Stahl; Lorna M Friis; Harald Nothaft; Xin Liu; Jianjun Li; Christine M Szymanski; Alain Stintzi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

10.  Characterization of an acid-inducible sulfatase in Salmonella enterica serovar typhimurium.

Authors:  Seema Das; Swati Singh; Michael McClelland; Steven Forst; Prasad Gyaneshwar
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.